I am excited to continue Ovation's drive to offer novel technologies, top-notch laboratory services, and positive patient experiences throughout the entirety of our network in the years to come.
LOS ANGELES (PRWEB) November 05, 2019
Ovation® Fertility has promoted Matthew “Tex” VerMilyea, PhD, HCLD/CC, to a newly created position of vice president of IVF lab operations. In this new senior management role, Dr. VerMilyea serves as a scientific resource and operational advocate for the nationwide network of Ovation IVF labs and is responsible for facilitating clinical collaboration across Ovation’s laboratory teams. He will also continue working to build existing and new relationships within the fertility care community, securing Ovation’s leadership role in accessing and further developing the latest technologies and research.
Dr. VerMilyea is uniquely positioned to evaluate procedures and outcomes and develop best practices to continuously improve performance across Ovation’s scientific teams.
“Dr. VerMilyea has a rare skillset, as he understands the demands of running an IVF lab, is a prolific researcher pushing the boundaries of innovation in fertility care, and also has a strong grasp on the operational complexities of scientific collaboration across multiple laboratory teams serving different nationwide markets,” says Ovation co-founder and Chief Executive Officer Nate Snyder. “He is ideally qualified to help us enhance collaboration; keep pace with rapid clinical and scientific advances in fertility care; and build excellent relationships with providers, suppliers and researchers in our field.”
Dr. VerMilyea joined Ovation in 2015 with the acquisition of Austin IVF, which was one of two IVF laboratories in Texas where he served as lab director. In addition to his vice president role, he will maintain lab and scientific directorship oversight for the Ovation Fertility Austin and Ovation Fertility San Antonio IVF labs. He is board certified as both a clinical consultant and a high complexity clinical laboratory director and is well-known within the IVF research community for leading innovative, collaborative studies to advance the science of fertility care, including award-nominated research involving the use of artificial intelligence in IVF. He is frequently invited to present Ovation collaborative studies’ findings at the largest fertility care conferences in the United States and abroad.
“As we look to the future and the possibilities that lie ahead at Ovation, I couldn't be more delighted to lead this phenomenal team of experienced and collaborative laboratory directors and scientists,” says Dr. VerMilyea. “I am also exceedingly proud to continue being a part of such an innovative and dynamic company. I am excited to continue Ovation's drive to offer novel technologies, top-notch laboratory services, and positive patient experiences throughout the entirety of our network in the years to come.”
Dr. VerMilyea received his bachelor of science degree from Cornell University and his PhD in genetics from The University of Birmingham in the United Kingdom. He then completed post-doctoral fellowships in the chromatin and gene expression laboratories at the Institute of Biomedical Research in Birmingham, UK. He was later selected as a research fellow for the Japan Society for the Promotion of Science, where he completed a second fellowship in the Laboratory of Mammalian Molecular Embryology at the RIKEN Institute in Kobe, Japan.
Learn more about Ovation and Dr. VerMilyea at http://www.OvationFertility.com.
About Ovation Fertility
Ovation® Fertility is a national network of reproductive endocrinologists and scientific thought leaders focused on reducing the cost of having a family through more efficient and effective fertility care. Ovation’s IVF and genetics laboratories, along with affiliated physician practices, work collaboratively to raise the bar for IVF treatment, with state-of-the-art, evidence-based fertility services that give hopeful parents the best chance for a successful pregnancy. Physicians partner with Ovation to offer their patients advanced preconception carrier screening; preimplantation genetic testing; donor egg and surrogacy services; and secure storage for their frozen eggs, embryos and sperm. Ovation also helps IVF labs across America improve their quality and performance with expert off-site lab direction and consultation. Learn more about Ovation’s vision of a world without infertility at http://www.OvationFertility.com.